Form 8-K - Current report:
SEC Accession No. 0001193125-20-196288
Filing Date
2020-07-21
Accepted
2020-07-21 16:02:00
Documents
5
Period of Report
2020-07-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d47591d8k.htm 8-K 21997
2 EX-3.1 d47591dex31.htm EX-3.1 24609
3 EX-3.2 d47591dex32.htm EX-3.2 163499
4 EX-99.1 d47591dex991.htm EX-99.1 6271
5 GRAPHIC g47591g66k31.jpg GRAPHIC 4666
  Complete submission text file 0001193125-20-196288.txt   224132
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 201038934
SIC: 2834 Pharmaceutical Preparations